VPIM
KYTX icon

Vanguard Personalized Indexing Management’s Kyverna Therapeutics KYTX Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio KYTX Stock Details KYTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$162K Sell
18,747
-301
-2% -$2.51K ﹤0.01% 1875
2025
Q4 		$179K Buy
19,048
+155
+0.8% +$1.15K ﹤0.01% 1742
2025
Q3 		$113K Sell
18,893
-229
-1% -$915 ﹤0.01% 1798
2025
Q2 		$58.7K Buy
19,122
+3,847
+25% +$9.52K ﹤0.01% 1807
2025
Q1 		$29.5K Buy
+15,275
New +$45.1K ﹤0.01% 1730

Other funds holding KYTX

GGI
GordonMD Global Investments Beverely Hills, California $144M AUM
GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
IHG
Insight Holdings Group New York $1.42B AUM 41.03% 1-Year Est. Return

Vanguard Personalized Indexing Management's KYTX Position: Q1 2026 in Review

Vanguard Personalized Indexing Management reduced its Kyverna Therapeutics (KYTX) stake by 1.6% in Q1 2026, selling an estimated $2.51K and leaving 18,747 shares worth $162K. The position accounts for ﹤0.01% of the portfolio, ranked #1875.

Vanguard Personalized Indexing Management first reported a position in KYTX in Q1 2025 and has held it in 5 quarters since. The position peaked at $179K in Q4 2025. 111 funds tracked by Wall St. Rank hold KYTX as of Q1 2026.

  • Vanguard Personalized Indexing Management held 18,747 shares of Kyverna Therapeutics worth $162K as of Q1 2026.
  • Vanguard Personalized Indexing Management sold 301 Kyverna Therapeutics shares in Q1 2026, an estimated $2.51K.
  • Kyverna Therapeutics made up ﹤0.01% of Vanguard Personalized Indexing Management's portfolio in Q1 2026, its #1875 holding.
  • Vanguard Personalized Indexing Management first reported a position in Kyverna Therapeutics in Q1 2025 and has held it in 5 quarters since.
  • Vanguard Personalized Indexing Management's Kyverna Therapeutics position peaked at $179K in Q4 2025.
  • 111 funds tracked by Wall St. Rank held Kyverna Therapeutics as of Q1 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q1 2026, filed 14 May 2026.